May 1
|
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
|
Apr 29
|
Arcturus Therapeutics Holdings' (NASDAQ:ARCT) investors will be pleased with their impressive 284% return over the last five years
|
Apr 25
|
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
|
Mar 28
|
Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
|
Mar 22
|
Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...
|
Mar 17
|
Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Mar 9
|
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
|
Mar 8
|
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript
|
Mar 8
|
Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call
|
Mar 8
|
Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments
|
Mar 7
|
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
|
Mar 7
|
Arcturus Therapeutics: Q4 Earnings Snapshot
|
Mar 7
|
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
|
Mar 4
|
Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
|
Dec 21
|
CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
|
Dec 8
|
12 Best Healthcare Stocks For the Long-Term
|
Dec 4
|
Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 1
|
The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
|
Nov 30
|
Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
|
Nov 28
|
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults
|